Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Acetaminophen | The serum concentration of Acetaminophen can be increased when it is combined with Geldanamycin. |
| Propacetamol | The serum concentration of Propacetamol can be increased when it is combined with Geldanamycin. |
| Salmon calcitonin | The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Geldanamycin. |
| Thyrotropin alfa | The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Geldanamycin. |
| Follitropin | The therapeutic efficacy of Follitropin can be decreased when used in combination with Geldanamycin. |
| Liothyronine | The therapeutic efficacy of Liothyronine can be decreased when used in combination with Geldanamycin. |
| Carbimazole | The therapeutic efficacy of Carbimazole can be decreased when used in combination with Geldanamycin. |
| Levothyroxine | The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Geldanamycin. |
| Propylthiouracil | The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Geldanamycin. |
| Methimazole | The therapeutic efficacy of Methimazole can be decreased when used in combination with Geldanamycin. |
| Liotrix | The therapeutic efficacy of Liotrix can be decreased when used in combination with Geldanamycin. |
| 3,5-Diiodotyrosine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Geldanamycin. |
| Tiratricol | The therapeutic efficacy of Tiratricol can be decreased when used in combination with Geldanamycin. |
| Parathyroid hormone | The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Geldanamycin. |
| Teriparatide | The therapeutic efficacy of Teriparatide can be decreased when used in combination with Geldanamycin. |
| Potassium Iodide | The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Geldanamycin. |
| Dibromotyrosine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Geldanamycin. |
| Thyroid, porcine | The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Geldanamycin. |
| Potassium perchlorate | The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Geldanamycin. |
| Protirelin | The therapeutic efficacy of Protirelin can be decreased when used in combination with Geldanamycin. |
| 3,5-diiodothyropropionic acid | The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Geldanamycin. |
| Methylthiouracil | The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Geldanamycin. |
| Elcatonin | The therapeutic efficacy of Elcatonin can be decreased when used in combination with Geldanamycin. |
| Benzylthiouracil | The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Geldanamycin. |
| Thyrotropin | The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Geldanamycin. |
| Darbepoetin alfa | The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Geldanamycin. |
| Erythropoietin | The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin. |
| Peginesatide | The risk or severity of Thrombosis can be increased when Peginesatide is combined with Geldanamycin. |
| Methoxy polyethylene glycol-epoetin beta | The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Geldanamycin. |
| Lidocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Lidocaine. |
| Ropivacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Ropivacaine. |
| Bupivacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Bupivacaine. |
| Cinchocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Cinchocaine. |
| Dyclonine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Dyclonine. |
| Procaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Procaine. |
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Prilocaine. |
| Proparacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Proparacaine. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Meloxicam. |
| Oxybuprocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Oxybuprocaine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Cocaine. |
| Mepivacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Mepivacaine. |
| Levobupivacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Levobupivacaine. |
| Diphenhydramine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Diphenhydramine. |
| Benzocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Benzocaine. |
| Chloroprocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Chloroprocaine. |
| Phenol | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Phenol. |
| Tetrodotoxin | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Tetrodotoxin. |
| Benzyl alcohol | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Benzyl alcohol. |
| Capsaicin | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Capsaicin. |
| Etidocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Etidocaine. |
| Articaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Articaine. |
| Tetracaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Tetracaine. |
| Propoxycaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Propoxycaine. |
| Pramocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Pramocaine. |
| Butamben | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Butamben. |
| Butacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Butacaine. |
| Oxetacaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Oxetacaine. |
| Ethyl chloride | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Ethyl chloride. |
| Butanilicaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Butanilicaine. |
| Metabutethamine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Metabutethamine. |
| Quinisocaine | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Quinisocaine. |
| Voriconazole | The serum concentration of Geldanamycin can be increased when it is combined with Voriconazole. |
| Nelarabine | The risk or severity of adverse effects can be increased when Nelarabine is combined with Geldanamycin. |
| Ambroxol | The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Ambroxol. |
| Etrasimod | The risk or severity of immunosuppression can be increased when Geldanamycin is combined with Etrasimod. |
| Palopegteriparatide | The therapeutic efficacy of Palopegteriparatide can be decreased when used in combination with Geldanamycin. |